
Keli L. Hill
Examiner (ID: 14362, Phone: (571)272-4375 , Office: P/2912 )
| Most Active Art Unit | 2912 |
| Art Unit(s) | 2912, 2922, 2952 |
| Total Applications | 3649 |
| Issued Applications | 3514 |
| Pending Applications | 12 |
| Abandoned Applications | 123 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5997022
[patent_doc_number] => 20110016537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'Cellular model of tauopathies for lead identification and drug discovery'
[patent_app_type] => utility
[patent_app_number] => 10/571934
[patent_app_country] => US
[patent_app_date] => 2004-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22167
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20110016537.pdf
[firstpage_image] =>[orig_patent_app_number] => 10571934
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/571934 | Cellular model of tauopathies for lead identification and drug discovery | Sep 15, 2004 | Abandoned |
Array
(
[id] => 7142784
[patent_doc_number] => 20050118172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'CDw52-specific antibody for treatment of multiple sclerosis'
[patent_app_type] => utility
[patent_app_number] => 10/938874
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1830
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938874
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938874 | CDw52-specific antibody for treatment of multiple sclerosis | Sep 12, 2004 | Abandoned |
Array
(
[id] => 463134
[patent_doc_number] => 07238529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-03
[patent_title] => 'Methods and compositions for treating ocular disorders'
[patent_app_type] => utility
[patent_app_number] => 10/933684
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3933
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/238/07238529.pdf
[firstpage_image] =>[orig_patent_app_number] => 10933684
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/933684 | Methods and compositions for treating ocular disorders | Sep 2, 2004 | Issued |
Array
(
[id] => 7127853
[patent_doc_number] => 20050059597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Method of reducing injury to mammalian cells'
[patent_app_type] => utility
[patent_app_number] => 10/930192
[patent_app_country] => US
[patent_app_date] => 2004-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 29449
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059597.pdf
[firstpage_image] =>[orig_patent_app_number] => 10930192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/930192 | Method of screening peptides useful in treating traumatic injury to the brain or spinal cord | Aug 30, 2004 | Issued |
Array
(
[id] => 6939723
[patent_doc_number] => 20050113286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Methods for treating congestive heart failure'
[patent_app_type] => utility
[patent_app_number] => 10/931498
[patent_app_country] => US
[patent_app_date] => 2004-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11348
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113286.pdf
[firstpage_image] =>[orig_patent_app_number] => 10931498
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/931498 | Methods for treating congestive heart failure | Aug 30, 2004 | Abandoned |
Array
(
[id] => 7074720
[patent_doc_number] => 20050147988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'H. pylori FlbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori FlbA polypeptides, and compositions for detection of an infection comprising H. pylori FlbA polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/926270
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 15978
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20050147988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926270
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926270 | H. pylori FlbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori FlbA polypeptides, and compositions for detection of an infection comprising H. pylori FlbA polypeptides | Aug 25, 2004 | Abandoned |
Array
(
[id] => 5501675
[patent_doc_number] => 20090162363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'PEDF-R RECEPTOR AND USES'
[patent_app_type] => utility
[patent_app_number] => 10/566540
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 52834
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162363.pdf
[firstpage_image] =>[orig_patent_app_number] => 10566540
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/566540 | PEDF-R RECEPTOR AND USES | Aug 4, 2004 | Abandoned |
Array
(
[id] => 7353279
[patent_doc_number] => 20040249128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Molecules for disease detection and treatment'
[patent_app_type] => new
[patent_app_number] => 10/483512
[patent_app_country] => US
[patent_app_date] => 2004-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63492
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20040249128.pdf
[firstpage_image] =>[orig_patent_app_number] => 10483512
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/483512 | Molecules for disease detection and treatment | Jul 18, 2004 | Abandoned |
Array
(
[id] => 5241738
[patent_doc_number] => 20070020230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Use of chemokines, and pharmaceutical preparations containing the same'
[patent_app_type] => utility
[patent_app_number] => 10/565226
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5955
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020230.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565226
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565226 | Use of chemokines, and pharmaceutical preparations containing the same | Jul 8, 2004 | Abandoned |
Array
(
[id] => 7275645
[patent_doc_number] => 20040235096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Method for regulating dopamine producing cells'
[patent_app_type] => new
[patent_app_number] => 10/487176
[patent_app_country] => US
[patent_app_date] => 2004-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5914
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235096.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487176
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487176 | Method for regulating dopamine producing cells | Jul 5, 2004 | Abandoned |
Array
(
[id] => 7328573
[patent_doc_number] => 20040253683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Cryptopain compositions for prophylaxis, treatment, diagnosis and detection of cryptosporidium species'
[patent_app_type] => new
[patent_app_number] => 10/867888
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12245
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10867888
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/867888 | Cryptopain compositions for prophylaxis, treatment, diagnosis and detection of cryptosporidium species | Jun 13, 2004 | Abandoned |
Array
(
[id] => 7329786
[patent_doc_number] => 20040254114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Polynucleotides encoding truncated glial cell line-derived neurotrophic factor'
[patent_app_type] => new
[patent_app_number] => 10/855820
[patent_app_country] => US
[patent_app_date] => 2004-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22865
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254114.pdf
[firstpage_image] =>[orig_patent_app_number] => 10855820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/855820 | Polynucleotides encoding truncated glial cell line-derived neurotrophic factor | May 25, 2004 | Issued |
Array
(
[id] => 7276288
[patent_doc_number] => 20040235739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Neuroprotective methods and reagents'
[patent_app_type] => new
[patent_app_number] => 10/849704
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26357
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235739.pdf
[firstpage_image] =>[orig_patent_app_number] => 10849704
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/849704 | Neuroprotective methods and reagents | May 18, 2004 | Abandoned |
Array
(
[id] => 6990902
[patent_doc_number] => 20050089939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer\'s disease pathology'
[patent_app_type] => utility
[patent_app_number] => 10/842212
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15619
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089939.pdf
[firstpage_image] =>[orig_patent_app_number] => 10842212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/842212 | Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology | May 9, 2004 | Abandoned |
Array
(
[id] => 7348070
[patent_doc_number] => 20040192889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof'
[patent_app_type] => new
[patent_app_number] => 10/472812
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14284
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192889.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472812
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472812 | Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof | May 5, 2004 | Abandoned |
Array
(
[id] => 170397
[patent_doc_number] => 07662620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Human and mammalian stem cell-derived neuron survival factors'
[patent_app_type] => utility
[patent_app_number] => 10/833108
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 17
[patent_no_of_words] => 8763
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662620.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833108
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833108 | Human and mammalian stem cell-derived neuron survival factors | Apr 27, 2004 | Issued |
Array
(
[id] => 7211766
[patent_doc_number] => 20050054040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Novel human semaphorin homologs and polynucleotides encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/833509
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8860
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054040.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833509
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833509 | Human semaphorin homologs and polynucleotides encoding the same | Apr 27, 2004 | Issued |
Array
(
[id] => 7404747
[patent_doc_number] => 20040175691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Use of the KCNQ2 and KCNQ3 genes for the discovery of agents useful in the treatment of neurological disorders'
[patent_app_type] => new
[patent_app_number] => 10/820307
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9340
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175691.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820307
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820307 | Use of the KCNQ2 and KCNQ3 genes for the discovery of agents useful in the treatment of neurological disorders | Apr 7, 2004 | Abandoned |
Array
(
[id] => 7263662
[patent_doc_number] => 20040241762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Assessing neuronal damage from blood samples'
[patent_app_type] => new
[patent_app_number] => 10/810388
[patent_app_country] => US
[patent_app_date] => 2004-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6568
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241762.pdf
[firstpage_image] =>[orig_patent_app_number] => 10810388
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/810388 | Assessing neuronal damage from blood samples | Mar 25, 2004 | Abandoned |
Array
(
[id] => 5662086
[patent_doc_number] => 20060252682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Liquid growth hormone formulation and process of preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/549763
[patent_app_country] => US
[patent_app_date] => 2004-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14889
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10549763
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/549763 | Liquid growth hormone formulation and process of preparation thereof | Mar 10, 2004 | Abandoned |